Caroline Palomeque
Stock Analyst at Berenberg
(1.80)
# 2,191
Out of 4,479 analysts
10
Total ratings
66.67%
Success rate
25.92%
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings | Initiates: Buy | $59 | $30.00 | +96.67% | 1 | Sep 7, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $154 | $177.61 | -13.29% | 1 | Sep 7, 2023 | |
| HALO Halozyme Therapeutics | Reinstates: Buy | $58 | $51.30 | +13.06% | 1 | Mar 27, 2023 | |
| CERE Cerevel Therapeutics Holdings | Reinstates: Hold | $22 | $41.23 | -46.64% | 1 | Mar 16, 2023 | |
| ASND Ascendis Pharma | Assumes: Buy | $166 | $136.27 | +21.82% | 1 | Aug 30, 2022 | |
| DNLI Denali Therapeutics | Initiates: Buy | $39 | $21.74 | +79.39% | 1 | Jun 23, 2022 | |
| RGNX REGENXBIO | Initiates: Buy | $61 | $10.75 | +467.44% | 1 | Jun 23, 2022 | |
| AVXL Anavex Life Sciences | Initiates: Buy | $40 | $4.13 | +868.52% | 1 | Jun 23, 2022 | |
| AGRX Agile Therapeutics | Downgrades: Hold | n/a | $1.41 | - | 1 | Apr 8, 2022 | |
| DARE Daré Bioscience | Initiates: Buy | n/a | $3.63 | - | 1 | Aug 17, 2018 |
Harmony Biosciences Holdings
Sep 7, 2023
Initiates: Buy
Price Target: $59
Current: $30.00
Upside: +96.67%
Krystal Biotech
Sep 7, 2023
Initiates: Buy
Price Target: $154
Current: $177.61
Upside: -13.29%
Halozyme Therapeutics
Mar 27, 2023
Reinstates: Buy
Price Target: $58
Current: $51.30
Upside: +13.06%
Cerevel Therapeutics Holdings
Mar 16, 2023
Reinstates: Hold
Price Target: $22
Current: $41.23
Upside: -46.64%
Ascendis Pharma
Aug 30, 2022
Assumes: Buy
Price Target: $166
Current: $136.27
Upside: +21.82%
Denali Therapeutics
Jun 23, 2022
Initiates: Buy
Price Target: $39
Current: $21.74
Upside: +79.39%
REGENXBIO
Jun 23, 2022
Initiates: Buy
Price Target: $61
Current: $10.75
Upside: +467.44%
Anavex Life Sciences
Jun 23, 2022
Initiates: Buy
Price Target: $40
Current: $4.13
Upside: +868.52%
Agile Therapeutics
Apr 8, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.41
Upside: -
Daré Bioscience
Aug 17, 2018
Initiates: Buy
Price Target: n/a
Current: $3.63
Upside: -